Wall Street analysts revise ratings and price targets
Sept. 18 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amrize, Carmax and VF Corp, on Friday.
Highlights
Amrize AG AMRZ.N: Jefferies cuts target price to $42.80 from $51.10
Carmax Inc KMX.N: JP Morgan raises target price to $70 from $60
Netflix Inc NFLX.O: Wells Fargo cuts to underweight from equal weight
Phillips 66 PSX.N: BMO raises target price to $310 from $260
VF Corp VFC.N: Deutsche Bank resumes coverage with hold rating
Following is a summary of research actions on U.S. companies reported by Reuters on Friday. Stock entries are in alphabetical order.
Alcoa Corporation AA.N: Wells Fargo cuts target price to $60 from $71
Allstate Corp ALL.N: Mizuho raises target price to $300 from $297
Amrize AG AMRZ.N: Jefferies cuts target price to $42.80 from $51.10
Amrize Ltd. AMRZ.N: Oppenheimer cuts target price to $55 from $62
Array Technologies Inc ARRY.O: UBS cuts target price to $5 from $10
Array Technologies Inc ARRY.O: UBS cuts to neutral from buy
Autozone, Inc. AZO.N: Oppenheimer cuts target price to $3500 from $4300
Brinker International Inc EAT.N: JP Morgan cuts target price to $245 from $250
Carmax Inc KMX.N: JP Morgan raises target price to $70 from $60
Century Aluminum Company CENX.O: Wells Fargo cuts target price to $79 from $83
Chord Energy Corporation CHRD.O: Jefferies raises target price to $150 from $133
Ciena Corporation CIEN.N: Barclays raises target price to $548 from $475
Cognizant CTSH.O: Deutsche Bank raises target price to $70 from $65
Conagra Brands CAG.N: Deutsche Bank raises target price to $13 from $12
Crowdstrike CRWD.O: Stephens raises target price to $280 from $260
Cue Biopharma, Inc. CUE.O: B. Riley initiates coverage with buy rating; target price $83
Dexcom Inc DXCM.O: Truist Securities raises target price to $102 from $93
Draftkings Inc. DKNG.O: UBS cuts target price to $48 from $49
Dynatrace Inc DT.N: Needham raises to buy from hold
Element Solutions Inc ESI.N: UBS cuts target price to $47 from $49
SPY•
